NCT00006489View on ClinicalTrials.gov

Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone)

PHASE4CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
AlcoholismAlcohol DependencePost-Traumatic Stress Disorder
Interventions
BEHAVIORAL

Cognitive-Behavioral Therapy

Twelve weekly 90-minute individual therapy sessions followed by (6) 90-minute sessions every other week

DRUG

Naltrexone

Daily dosing 100 mg for 24 weeks

DRUG

Placebo

Pill Placebo daily dosing 24 weeks

Trial Locations (1)

19104

Center for Anxiety, University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Pennsylvania

OTHER

NCT00006489 - Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone) | Biotech Hunter | Biotech Hunter